Product NDC: | 50474-100 |
Proprietary Name: | Theo-24 |
Non Proprietary Name: | theophylline anhydrous |
Active Ingredient(s): | 100 mg/1 & nbsp; theophylline anhydrous |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50474-100 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087942 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980421 |
Package NDC: | 50474-100-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-100-01) |
NDC Code | 50474-100-01 |
Proprietary Name | Theo-24 |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-100-01) |
Product NDC | 50474-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | theophylline anhydrous |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19980421 |
Marketing Category Name | ANDA |
Labeler Name | UCB, Inc. |
Substance Name | THEOPHYLLINE ANHYDROUS |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |